{"summary":"\u2022 Solides connaissances en oncologie notamment dans le domaine des ADCs (antibody drug conjugate)\n\n\u2022 Grand sens du relationnel et de la collaboration d\u00e9montr\u00e9s par la mise en place de projets collaboratifs cross-fonctionnel nationaux et r\u00e9gionaux avec les KOL en IDF et dans la r\u00e9gion Est\n\n\u2022 Excellente comp\u00e9tence en communication (orale et \u00e9crite) d\u00e9montr\u00e9e par 11 ann\u00e9es d'exp\u00e9rience en tant que formatrice,  enseignante et MSL ayant permis de d\u00e9velopper ma capacit\u00e9 de transmettre des informations m\u00e9dico-scientifiques claires face \u00e0 un auditoire vari\u00e9.\n\n\u2022 Soutien \u00e0 la recherche clinique dans les principaux grands centres parisiens en tant que coordinatrice des essais cliniques pour l'\u00e9quipe m\u00e9dicale France","lastName":"Laurient\u00e9","objectUrn":"urn:li:member:442358255","geoRegion":"Villeron, \u00cele-de-France, France","fullName":"Vanessa Laurient\u00e9","firstName":"Vanessa","currentPositions":[{"companyName":"Seagen","description":"Support the Tucatinib (TKI) medical strategy and launch activities in the IDF area in line with national and\nregional medical plan including execution of cohort ATU.\n\u2022 Identify, create and foster credible relationships with experts in Oncology (multi tumor types) in Paris area by engaging ongoing and balanced scientific exchanges.\n\u2022 Participate in building of the SEAGEN France affiliate and establish Seagen footprint in IDF area.\n\u2022 Active listening during scientific exchanges leading to the implementation\/monitoring of 3 investigator\nsponsored trial (IST) including an international IST with Curie Institute & HEGP\/UK\n\u2022 Strong expertise in antibody-drug conjugate (ADC) and Sugar engineering antibody (SEA) combined with intensive continuing education (IGR\/Curie masterclasses and personalized training by top KOLs) allowing to maintain strong expertise in oncology.\n\u2022 Active medical support for sponsored global clinical trials and clinical development team (18 clinical\ndevelopment programs):\n\u2022 Attend to feasibility & site initiation visits, monitoring of inclusions in SEAGEN sponsored trials (lung,\nupper\/low GI, urology, gynecology, head and neck, breast cancers) requiring strong medical and scientific knowledges of several tumor types and strong collaboration with clinical development team.\n\u2022 National medical team coordinator for gynecological\/head and neck oncology trials (1st ADC in cervical cancer)\n\u2022 Management of regional projects (symposia, webinar, IME) in partnership with experts from anti-cancer\ncenters (Curie, IGR), private practice institute (Hartmann) even resulting in an exclusive partnership for the presentation of regional breast cancer guidelines.\n\u2022 Management of national projects (seminar, digital week in oncology, national webinars, IME) and national congresses with management of top KOL and validation of scientific content (IFODS, SFSPM, MAO\/WAO, GINECO days)\n\u2022 Management of 1 national boards with inter\/national experts","title":"MSL oncology Paris IDF chez Seagen ","companyUrnResolutionResult":{"employeeCountRange":"1001-5000","headquarters":{"geographicArea":"Washington","country":"United States","city":"Bothell","postalCode":"98021","line1":"21823 30th Dr SE"},"revenue":{"amount":"4.8225E+8","currencyCode":"USD"},"flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/seagen\/","formattedRevenue":{"unit":"MILLION","amount":482.3,"currencyCode":"USD"},"industry":"Biotechnology Research"},"companyUrn":"urn:li:fs_salesCompany:21407","tenureAtCompany":{"numYears":3,"numMonths":5},"startedOn":{"month":1,"year":2021}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABpd2e8BWEJOPK8myDxETxua9yTo6vejlaQ,NAME_SEARCH,fG4V)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1558346757569?e=1723075200&v=beta&t=mk4uxHTOf2Vai6OG-SymMHAelf8uu32Q3dzgt5WCR2o","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1558346757722?e=1723075200&v=beta&t=gxqQHQh7O4rXpCq9EtSimY1hfhW5BirouFW9ul8KWPI","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1558346757613?e=1723075200&v=beta&t=KXzd0lCAQVyBKpeVlUx_9saDOUUzRuHdR-g_lqEJtAM","height":400},{"width":500,"fileIdentifyingUrlPathSegment":"800_800\/0\/1558346757490?e=1723075200&v=beta&t=Q5pWDfxSFm4NUHHcGNTl90wv41JSaao9jyh40omuCwc","height":500}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQEqea0aXJ8mqg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2018},"degree":"MBA Managemen et  Biotechnologies","eduId":502276754,"schoolUrn":"urn:li:fs_salesSchool:15143970","school":"urn:li:fs_salesSchool:15143970","fieldsOfStudy":["Management and biotechnologies"],"schoolName":"Ionis-STM, \u00e9cole de double comp\u00e9tence","startedOn":{"year":2018}},{"endedOn":{"year":2016},"degree":"Doctorat","eduId":370249541,"schoolUrn":"urn:li:fs_salesSchool:652690","school":"urn:li:fs_salesSchool:652690","fieldsOfStudy":["Biologie cellulaire et mol\u00e9culaire \/ PhD in molecular and cell biology"],"schoolName":"Universit\u00e9 Paris 13","startedOn":{"year":2011}},{"endedOn":{"year":2011},"degree":"Master 2 (M2)\/ Master's degree","eduId":298699118,"schoolUrn":"urn:li:fs_salesSchool:652690","school":"urn:li:fs_salesSchool:652690","fieldsOfStudy":["Biomol\u00e9cules et th\u00e9rapies exp\u00e9rimentales\/ Biomolecules et experimental therapies"],"schoolName":"Universit\u00e9 Paris Nord- Paris 13","startedOn":{"year":2010}},{"endedOn":{"year":2004},"degree":"Baccalaur\u00e9at Scientifique, SVT","schoolName":"Lyc\u00e9e Maurice Utrillo, Stains","startedOn":{"year":2001},"eduId":502276712}],"skills":[{"numOfEndorsement":1,"name":"Biologie cellulaire et mol\u00e9culaire"},{"numOfEndorsement":2,"name":"Oncologie"},{"numOfEndorsement":0,"name":"Management"},{"numOfEndorsement":1,"name":"Biochimie"},{"numOfEndorsement":0,"name":"Marketing BtoB"},{"numOfEndorsement":0,"name":"R\u00e9action en cha\u00eene par polym\u00e9rase"},{"numOfEndorsement":0,"name":"Transfert de prot\u00e9ines"},{"numOfEndorsement":0,"name":"qPCR"},{"numOfEndorsement":0,"name":"Recherche"},{"numOfEndorsement":1,"name":"G\u00e9n\u00e9tique"},{"numOfEndorsement":0,"name":"Microscopie"},{"numOfEndorsement":0,"name":"Sciences de la vie"},{"numOfEndorsement":0,"name":"Culture de cellules"},{"numOfEndorsement":2,"name":"Biologie mol\u00e9culaire"},{"numOfEndorsement":1,"name":"Biologie cellulaire"},{"numOfEndorsement":0,"name":"Biotechnologie"},{"numOfEndorsement":0,"name":"Spectrom\u00e9trie de masse"},{"numOfEndorsement":0,"name":"Purification"},{"numOfEndorsement":0,"name":"Gestion de projet"},{"numOfEndorsement":0,"name":"Cytom\u00e9trie en flux"},{"numOfEndorsement":0,"name":"ELISA"},{"numOfEndorsement":0,"name":"Microscope confocal"},{"numOfEndorsement":0,"name":"Immunologie"},{"numOfEndorsement":0,"name":"RT-PCR"},{"numOfEndorsement":0,"name":"Microscopie \u00e0 fluorescence"},{"numOfEndorsement":1,"name":"Analyse de donn\u00e9es"},{"numOfEndorsement":0,"name":"Marketing digital"},{"numOfEndorsement":0,"name":"Microsoft PowerPoint"},{"numOfEndorsement":0,"name":"Microsoft Word"},{"numOfEndorsement":0,"name":"Adobe Photoshop"},{"numOfEndorsement":0,"name":"Microsoft Excel"},{"numOfEndorsement":0,"name":"Windows"},{"numOfEndorsement":0,"name":"Macintosh"},{"numOfEndorsement":0,"name":"Enseignement"},{"numOfEndorsement":0,"name":"Anglais professionnel"},{"numOfEndorsement":1,"name":"Marketing strat\u00e9giques et operationel des produits de Sant\u00e9"},{"numOfEndorsement":0,"name":"\u00c9conomie de la sant\u00e9"},{"numOfEndorsement":1,"name":"Etudes cliniques"},{"numOfEndorsement":1,"name":"Outils de communication dans le domaine de la sant\u00e9"},{"numOfEndorsement":0,"name":"Immunofluorescence"},{"numOfEndorsement":0,"name":"Immunopr\u00e9cipitation"},{"numOfEndorsement":0,"name":"Histologie"},{"numOfEndorsement":1,"name":"Veille scientifique et concurrentielle"},{"numOfEndorsement":0,"name":"D\u00e9marche marketing"},{"numOfEndorsement":2,"name":"Molecular Biology"},{"numOfEndorsement":1,"name":"Western Blotting"}],"numOfConnections":726,"patents":[],"headline":"MSL oncology Paris IDF chez Seagen France","courses":[],"certifications":[],"memberBadges":{"premium":true,"openLink":true,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/vanessa-laurient%C3%A9","organizations":[],"location":"Villeron, \u00cele-de-France, France","publications":[{"name":"Mutation of Vav1 adaptor region reveals a new oncogenic activation","publishedOn":{"month":10,"day":24,"year":2014},"publisher":"Oncotarget","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABpd2e8BWEJOPK8myDxETxua9yTo6vejlaQ,NAME_SEARCH,fG4V)"}]},{"name":"Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia","publishedOn":{"month":4,"day":26,"year":2016},"publisher":"Oncotarget","url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9031&path%5B%5D=27351","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABpd2e8BWEJOPK8myDxETxua9yTo6vejlaQ,NAME_SEARCH,fG4V)"}]}],"positions":null,"posts":[{"createdAt":1715162940000,"insightId":"c5f9aab8-5f78-49b8-bdbb-437ca8b22403","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7193915001730994176","threadUrn":"urn:li:ugcPost:7193915001730994176","reactionsCount":4,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193915001730994176","message":{"attributes":[],"text":"Journ\u00e9e mondiale cancer de l\u2019ovaire"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"title":{"text":"Journ\u00e9e mondiale du cancer de l'ovaire"},"mediaType":"PAGINATEDDOCUMENT"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193874258106707969","message":{"attributes":[{"start":976,"length":5,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:clcc"}}},{"start":1116,"length":28,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:journAezemondialecancerovaire"}}},{"start":1145,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:santAez"}}},{"start":1152,"length":22,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:sensibilisationcancer"}}},{"start":1175,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:prAezvention"}}}],"text":"\ud83c\udf97\ufe0f Le 8 mai\u2026 c\u2019est aussi la Journ\u00e9e Mondiale pour s\u2019informer sur les Cancers de l'Ovaire. \nLe cancer de l'ovaire ne repr\u00e9sente qu'un faible pourcentage des cancers f\u00e9minins. Mais c'est un cancer rare et souvent silencieux, diagnostiqu\u00e9 trop tardivement. Il n\u00e9cessite donc une attention particuli\u00e8re. \nConnaissez-vous les facteurs de risque et les moyens de pr\u00e9vention ?\n\n\ud83d\udd0d Les facteurs de risque peuvent inclure des ant\u00e9c\u00e9dents familiaux, notamment les mutations g\u00e9n\u00e9tiques h\u00e9r\u00e9ditaires BRCA, l'\u00e2ge avanc\u00e9, l'exposition \u00e0 l'amiante et le tabac\u2026 Il est crucial de rester vigilant et de suivre le calendrier des rendez-vous et examens gyn\u00e9cologiques.\n\n\ud83d\udca1 La pr\u00e9vention joue un r\u00f4le cl\u00e9. Il ne faut n\u00e9gliger aucun sympt\u00f4me. Vous ressentez des douleurs abdominales persistantes, des ballonnements, un manque d'app\u00e9tit, une fatigue inexpliqu\u00e9e, des changements dans les habitudes intestinales ou urinaires\u2026 Parlez-en \u00e0 votre m\u00e9decin traitant ou \u00e0 un professionnel de sant\u00e9.\n\nLes #CLCC et Unicancer sont mobilis\u00e9s. Encourageons la sensibilisation pour d\u00e9tecter ce cancer plus t\u00f4t et am\u00e9liorer les chances de gu\u00e9rison. \n\n#Journ\u00e9eMondialeCancerOvaire #Sant\u00e9 #SensibilisationCancer #Pr\u00e9vention"},"entityUrn":"urn:li:ugcPost:7193874258106707969"},"entityUrn":"urn:li:ugcPost:7193915001730994176"}}},{"createdAt":1715953740000,"insightId":"92f26de9-761d-4d84-87c2-f723d5b16b23","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196966768244916224,7197231706616070145)","threadUrn":"urn:li:ugcPost:7196966768244916224","reactionsCount":2,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"F\u00e9licitations Narcisa !\nC\u2019est le d\u00e9but d\u2019une belle aventure et ils sont chanceux chez DS !\nEncore une opportunit\u00e9 de mettre \u00e0 profit toute ton expertise et surtout toutes tes qualit\u00e9s humaines \u2026\u2026et je sais de quoi je parle !!!\n\u00c9clate toi dans ton nouveau job et \u00e0 tr\u00e8s bient\u00f4t"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196966768244916224"}}},{"createdAt":1712041140000,"insightId":"6d9009a0-61b6-4f49-9903-8f322e9304ac","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7180820385712476160,7180821046889971712)","threadUrn":"urn:li:ugcPost:7180820385712476160","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"F\u00e9licitations Guidado"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7180820385712476160"}}},{"createdAt":1711523520000,"insightId":"87553edf-641c-4096-baec-15be1a369c68","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7178428949281009665,7178650139736059905)","threadUrn":"urn:li:ugcPost:7178428949281009665","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Bravo !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7178428949281009665"}}},{"createdAt":1711063500000,"insightId":"7b3950ed-9b9d-4965-91e3-40a999eeea00","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7176314324070588416,7176720642317156352)","threadUrn":"urn:li:ugcPost:7176314324070588416","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Bravo !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7176314324070588416"}}},{"createdAt":1709621340000,"insightId":"1ca9d354-4a90-414c-8d16-16b09557792c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7170545899117367296,7170671631726432257)","threadUrn":"urn:li:activity:7170545899117367296","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"F\u00e9licitations !!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7170545899117367296"}}}]}